Instructions for Nifuratel-SZ 200 mg 20 tablets
Nifuratel-C3 200 mg 20 tablets
English product name
Nifuratel-SZ
Release Form
Coated tablets
Description:
Tablets covered with a film shell of yellow color, round, double-convex; The cross-section core of the pill is yellow.
1 tab.
nifuratel 200 mg
[PRING] corn starch - 90.7 mg,
gelatin - 2.3 mg,
polyethylene glycol 6000 (macrogol) - 15 mg,
talc - 9 mg,
magnesium stearate - 3 mg.
Shell Composition:
hypromellose - 5.37 mg,
polysorbate-80 (twin-80) - 1.5 mg,
talc - 1.5 mg,
titanium dioxide (E171) - 1.13 mg,
lacquer aluminum based dye quinoline yellow - 0.5 mg.
ATC codes
G01AX05 Nifuratel
Clinical-pharmacological groups / Group affiliation
Antibacterial drug, a derivative of nitrofuran
Active substance
Nifuratel
Pharmacotherapy group
Antimicrobial and anti-acid agent, nitrofuran
Storage conditions
The drug Nifuratel should be stored in a place inaccessible to children, protected from light at a temperature not higher than 25 ° C.
Best before date
Shelf life is 3 years. Do not apply after the expiry date indicated on the package.
Testimony:
vulvovaginal infections caused by drug-sensitive pathogens (pathogens, Candida fungi, trichomonades, bacteria, chlamydia);
pyelonephritis, urethritis, cystitis, pyelitis and other urinary system diseases;
intestinal amoebiasis and lambliasis;
chronic inflammatory upper gastrointestinal diseases associated with Helicobacter pylori infection.
Method of use, course and dosage:
The drug Nifuratel is taken internally following the recommendations.
Vaginal infections
Adults: 1 tablet 3 times/day after eating for 7 days (take the drug Nifuratel should both sexual partners).
Children older than 3 years and with a body weight of more than 20 kg: The recommended dose is 10 mg/kg body weight daily for 10 days. The recommended dose should be taken in two doses.
Urinary tract infections
Adults: depending on the severity of the disease, 1-2 tablets 3 times/day for 7-14 days.
Children over 3 years old and with a body weight of more than 20 kg: The recommended dose is 30-60 mg/kg body weight. The recommended dose should be taken in two intakes.
The treatment of urinary tract infections may be extended or repeated on the doctor's recommendation.
Intestinal amoebiasis
Adults: 2 tablets 2-3 times/day for 10 days.
Children older than 3 years and with a body weight of more than 20 kg: The recommended dose is 10 mg/kg body weight 3 times/day.
Lambliosis
Adults: 2 tablets 2-3 times/day for 7 days.
Children older than 3 years and with a body weight of more than 20 kg: The recommended dose is Po 15 mg/kg body weight 2 times/day for 7 days.
Upper gastrointestinal inflammatory diseases associated with Helicobacter pylori
Adults: 2 tablets 2-3 times/day for 7 days.
Children over 3 years old and with a body weight of more than 20 kg: The recommended dose is 15 mg/kg body weight 2 times/day for 7 days.
Use in children
The use of the preparation in children under 3 years of age and having a body mass of less than 20 kg is contraindicated.
- Nosology (ICD codes)
- A06
- Amebiaz
- A07.1
- Giardiasis [lambliosis]
- A56.0
- Chlamydia infections of the lower urinary tract
- A56.1
- Chlamydia infections of pelvic organs and other urinary organs
- A59
- Trichomoniasis
- B37.3
- Candidiasis vulva and vagina
- B98.0
- Helicobacter pylori as the cause of diseases classified in other categories
- K25
- stomach ulcer
- K26
- Duodenum ulcer
- N10
- Acute tubuloinsterstitial nephrite (acute pyelonephritis)
- N11
- Chronic tubulointerstitial nephritis (chronic pyelonephritis)
- N30
- Cystitis
- N34
- Urethritis and urethral syndrome
- N37.0
- Urethritis in diseases classified in other headings
- N76
- Other inflammatory diseases of the vagina and vulva
- N77.1
- Vaginitis, vulvite and vulvovaginitis for infectious and parasitic diseases classified in other headings
Pharmacological effect:
Antimicrobial agent from the group of nitrofurans; It has antibacterial, antifungal and antibacterial effects.
Nifuratel has high efficiency and low toxicity, which makes it suitable for a wide range of clinical applications.
It is highly active against Papiliobacter and Helicobacter pylori, gram-positive and gram-negative microorganisms. The spectrum of action includes: Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Shigella flexneri 2a, Shigella flexneri 6, Shigella sonnei, Salmonella typhi, Salmonella typhimurium, Salmonella enteritidis, Klebsiella spp, Enterobacter spp, Serratia spp, Citrobacter spp, Morganella spp., Rettgerella spp., other atypical enterobacteriaceae, and protozoa (trichomonades, amoebae, lamblia); is less active in Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa.
It is a drug Nifuratel of choice for the treatment of salmonellosis, shigellosis and other acute intestinal bacterial infections.
Active with regard to Trichomonas vaginalis, highly active with regard to fungi of the genus Candida.
It is particularly effective against metronidazole-resistant strains of Helicobacter pylori.
